Description
| Product Name | CAT.No | Size |
| CA125 | BXE0821A | 96T |
| CA15-3 | BXE0881A | 96T |
| CA19.9 | BXE0841A | 96T |
Product Description
The Biorex Diagnostics Cancer Antigen (CA) ELISA kits are quantitative microplate enzyme immunoassays (ELISAs) designed for the accurate and reproducible measurement of tumour-associated antigens, including CA-125, CA 19-9, and CA 15-3, in human serum or plasma. These antigens are widely recognised as clinically significant biomarkers in oncology, commonly associated with ovarian, gastrointestinal, and breast cancers. The reliable quantification of these markers is critical for diagnosis, therapeutic monitoring, and disease progression assessment.
Accurate detection of CA antigens supports early identification of malignancies, evaluation of treatment efficacy, and detection of cancer recurrence. These assays provide essential information for clinicians in guiding patient management, while also offering a valuable tool for research in oncology and translational studies. The ELISA microplate format ensures high throughput, reproducibility, and standardisation across laboratories.
Key Features
- Quantitative Microplate Assay: Enables precise and reproducible measurement of CA-125, CA 19-9, and CA 15-3 concentrations.
- High Sensitivity and Specificity: Detects clinically relevant cancer antigen levels, minimising false positives and false negatives.
- Colourimetric ELISA Format: Standardised enzyme-linked immunosorbent assay providing dependable optical readouts.
- Sample Compatibility: Validated for use with human serum and plasma, ensuring flexibility in clinical testing.
- Ready-to-Use Kit Components: Includes pre-formulated reagents, standards, and controls to streamline workflow and reduce handling errors.
- Quality-Controlled: Ensures consistent performance, accuracy, and reproducibility across multiple assays and laboratories.
The Biorex Diagnostics Cancer Antigen ELISA kits are a trusted solution for clinical laboratories, research institutions, and healthcare providers. By enabling precise and reliable measurement of tumour markers, these kits support the diagnosis and monitoring of ovarian, gastrointestinal, and breast cancers, aiding in clinical decision-making and improving patient outcomes. Their robust design, ease of use, and high throughput capability make them suitable for routine clinical diagnostics, patient management, and oncology research applications.
Contact Us for more information.